The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current ...
The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...
The FDA issued a warning letter to Sanofi regarding significant manufacturing violations at its Genzyme Corporation Facility in Framingham, Mass. The letter, dated Dec. 16, 2024, and amended Jan. 15, ...
Good morning! Here are the five things you need to know in local business news to start your busy — and still very cold — ...
Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a ...
Sisitsky submitted his plan to comply with the law late last month after city councilors voted to table discussing the issue until February.
Framingham officials got word on Wednesday that they were "conditionally compliant" under the MBTA Communities Act law. The City must submit an approvable economic feasibility analysis that supports ...